1. Home
  2. IRTC vs DNLI Comparison

IRTC vs DNLI Comparison

Compare IRTC & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

N/A

Current Price

$111.71

Market Cap

4.2B

Sector

Health Care

ML Signal

N/A

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

N/A

Current Price

$20.18

Market Cap

3.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IRTC
DNLI
Founded
2006
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.4B
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
IRTC
DNLI
Price
$111.71
$20.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
14
Target Price
$197.92
$34.33
AVG Volume (30 Days)
455.4K
1.1M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
61.71
N/A
EPS
N/A
N/A
Revenue
$747,138,000.00
N/A
Revenue This Year
$19.60
N/A
Revenue Next Year
$15.94
$408.85
P/E Ratio
N/A
N/A
Revenue Growth
26.24
N/A
52 Week Low
$100.85
$12.58
52 Week High
$210.01
$27.30

Technical Indicators

Market Signals
Indicator
IRTC
DNLI
Relative Strength Index (RSI) 39.20 31.95
Support Level $102.62 $18.86
Resistance Level $127.33 $20.84
Average True Range (ATR) 4.69 0.64
MACD -1.25 -0.28
Stochastic Oscillator 8.43 16.02

Price Performance

Historical Comparison
IRTC
DNLI

About IRTC iRhythm Technologies Inc.

iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Share on Social Networks: